Home » MHRA Criticizes EU Drug Verification Plan as Costly
MHRA Criticizes EU Drug Verification Plan as Costly
May 10, 2012
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is taking issue with an EU plan to scan all drugs at the point of dispensing, saying the cost of providing scanners at all healthcare outlets is too burdensome.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor